Related Experiment Video

Updated: May 3, 2026

Characterization at the Molecular Level using Robust Biochemical Approaches of a New Kinase Protein
11:23

Characterization at the Molecular Level using Robust Biochemical Approaches of a New Kinase Protein

Published on: June 30, 2019

6.0K

Discovery and Development of a Potent LIMK2 Isoform-Specific Degrader

Kamal Rayees Abdul Azeez1,2, Hayuningbudi Saraswati3, Thorsten Mosler4

  • 1Institute of Pharmaceutical Chemistry, Goethe University, Max-von-Laue-Str. 9, 60438 Frankfurt am Main, Germany.

ACS Chemical Biology
|May 1, 2026
PubMed

Insights

Researchers developed PROTACs to degrade LIM kinases (LIMK1/2), crucial for actin regulation. They achieved isoform-specific LIMK2 degradation, creating a potent chemical probe for disease research.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Drug Discovery

Background:

  • LIM kinases (LIMK1/2) regulate actin cytoskeleton dynamics through cofilin phosphorylation.
  • Dysregulation and overexpression of LIMKs are linked to diseases like cancer, Fragile X syndrome, and glaucoma.
  • LIM kinases are attractive drug targets due to their position downstream of Rho GTPase signaling.

Purpose of the Study:

  • To develop Proteolysis Targeting Chimeras (PROTACs) to disrupt both catalytic and non-catalytic functions of LIM kinases.
  • To investigate isoform-specific degradation of LIMK1 and LIMK2 using PROTAC technology.

Main Methods:

  • Design and optimization of PROTACs targeting LIMK1/2.
  • Cell-based assays to evaluate PROTAC efficacy and specificity.
  • Structural analysis to understand the basis of isoform selectivity.

Main Results:

  • Initial PROTACs demonstrated isoform-specific LIMK2 degradation, despite targeting both LIMK1/2 with a dual inhibitor warhead.
  • Optimization yielded a highly potent and selective LIMK2 degrader.
  • Isoform specificity is attributed to favorable orientation bias, lysine accessibility, and enhanced ternary complex formation.

Conclusions:

  • A novel chemical probe was developed for isoform-specific LIMK2 degradation.
  • This PROTAC offers a powerful alternative to conventional reversible pan-LIMK inhibitors.
  • The findings provide a new tool for studying LIMK functions and related diseases.

More Related Videos

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines05:33

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

Published on: November 9, 2020

11.7K
Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag08:55

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag

Published on: December 14, 2017

14.9K

Related Concept Videos

Regulated Protein Degradation02:58

Regulated Protein Degradation

2.5K
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
6.6K